SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Use of Estimates (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Use of Estimates [Abstract]
Revenues	$ 119,839			$ 67,275			$ 308,905	$ 184,311
Income from operations	39,638			8,685			100,660	7,399
Net income	$ 35,909	$ 32,062	$ 17,806	$ 2,565	$ (6,371)	$ (6,789)	$ 85,777	$ (10,594)
Basic earnings per share (in dollars per share)	$ 0.15			$ 0.01			$ 0.37	$ (0.05)
Diluted earnings per share (in dollars per share)	$ 0.15			$ 0.01			$ 0.35	$ (0.05)
Accrual adjustments	$ 27,535						$ 27,535		$ 32,919
Accrual for U.S. Medicaid Rebates [Member]
Use of Estimates [Abstract]
Revenues							12,600
Income from operations							12,600
Net income							$ 11,900
Basic earnings per share (in dollars per share)							$ 0.05
Diluted earnings per share (in dollars per share)							$ 0.05
Accrual adjustments	$ 12,600	$ 12,600					$ 12,600